Press Releases

Press Releases

News, Events, Updates, Breakthroughs

Journalists may direct questions to Or click here for direct contact information for Daiichi Sankyo U.S. Public Affairs team

Press announcements are archived by release date, searchable by topic:

From To
Date Title
Mon Mar 06 00:00:00 GMT-04:00 2017
Daiichi Sankyo, Inc. Initiates ENTRUST-AF PCI Study Investigating Once-Daily SAVAYSA® (edoxaban) in ...
PDF (297 KB)
Fri Feb 17 00:00:00 GMT-04:00 2017
Daiichi Sankyo and ArQule Announce the Completion of the METIV-HCC Phase 3 Study of Tivantinib in S ...
PDF (190 KB)
Fri Feb 03 00:00:00 GMT-04:00 2017
Charleston Laboratories, Inc. and Daiichi Sankyo, Inc. Receive Complete Response Letter from FDA f ...
PDF (47 KB)
Wed Jan 18 00:00:00 GMT-04:00 2017
Daiichi Sankyo Initiates Phase 1/2 Study of Novel Antibody Drug Conjugate U3-1402 in Patients with ...
PDF (178 KB)
Mon Dec 12 00:00:00 GMT-04:00 2016
Daiichi Sankyo and DarwinHealth Announce Strategic Partnership to Deploy a Quantitative Systems Bio ...
PDF (163 KB)
Mon Dec 05 00:00:00 GMT-04:00 2016
Daiichi Sankyo Presents Phase 1 Data for MDM2 Inhibitor DS-3032 in Acute Myeloid Leukemia and Myelo ...
PDF (193 KB)
Thu Dec 01 00:00:00 GMT-04:00 2016
U.S. FDA Grants Fast Track Designation for HER2-Targeting Antibody Drug Conjugate DS-8201 for HER2- ...
PDF (180 KB)
Wed Nov 30 00:00:00 GMT-04:00 2016
Daiichi Sankyo Highlights Clinical Data of Two Novel Hematological Agents at the 58th Annual Meetin ...
PDF (178 KB)
Mon Nov 07 00:00:00 GMT-04:00 2016
Daiichi Sankyo Announces New Subgroup Analyses of Once-Daily SAVAYSA® (edoxaban) in Patients with N ...
PDF (367 KB)
Showing 31 - 39 of 39 results.

Press Release More Stories

More Stories

Who We Are

As the U.S. subsidiary of a global pharmaceutical innovator, Daiichi Sankyo, Inc. draws on a rich heritage of innovation, integrity and accountability..

read more ...